about
Depressive symptoms as a risk factor for unintentional injury: a cohort study in a rural countyHow Do You Know Which Health Care Effectiveness Research You Can Trust? A Guide to Study Design for the PerplexedBright light treatment of depression for older adults [ISRCTN55452501]Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United StatesOpioid analgesics and the risk of fractures in older adults with arthritisDiscontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trialLong term benzodiazepine use for insomnia in patients over the age of 60: discordance of patient and physician perceptionsBenzodiazepine harm: how can it be reduced?Deciphering Medicaid data: issues and needsFrontal Lobe Function and Risk of Hip Fracture in Patient With Alzheimer Disease: An Analysis of Linked DataPharmacotherapy of depression in old age.Insomnia in the elderly.Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohort.Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.Medication use in residential care facilities for the elderly.Characteristics of physicians who frequently prescribe long-acting benzodiazepines for the elderly.Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults.Medications in older patientsPsychotropic drugs and the risk of fractures in old age: a prospective population-based studyEvaluation results from prospective drug utilization review: Medicaid demonstrationsMedication use as a risk factor for inpatient falls in an acute care hospital: a case-crossover study.The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach.Psychotropic drugs and falls: new evidence pertaining to serotonin reuptake inhibitors.Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.Circadian rhythms and sleep in human aging.Exposure to potentially harmful drug-disease interactions in older community-dwelling veterans based on the Healthcare Effectiveness Data and Information Set quality measure: who is at risk?Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategiesRisk of osteoporosis and fracture incidence in patients on antipsychotic medication.Development of an indicator to identify inappropriate use of benzodiazepines in elderly medical in-patients.Potentially inappropriate medications in the elderly: the PRISCUS list.Update in serotonin and bone.Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.Preserving mobility in older adultsAn investigation of the association of benzodiazepines and other hypnotics with the incidence of falls in the elderly.The SSRIs: advantages, disadvantages and differences.Questionable prescribing for elderly patients in Quebec.Relationship between use of antidepressants and risk of fractures: a meta-analysis.Neuroleptic drug utilization in out-patients--a prescription database study.Effect of temazepam on blood pressure regulation in healthy elderly subjects.Single dose pharmacodynamics of thioridazine and remoxipride in healthy younger and older volunteers.
P2860
Q23913384-417BCC3A-7CF9-4C82-B59D-A7F071DFB2C7Q24273264-C299A9EE-32AF-4ACF-A74C-0DA5F957A371Q24536720-BC485594-58BE-4641-8B0D-A1B52309204AQ24598759-A0A443DD-091A-40E8-9DFD-A8A3E64488A4Q24607425-F3A7EEDE-FEAE-4C15-8FC5-EBF100227C8BQ24650209-893FA213-EFFD-4A4C-B90B-E18A2BA4C089Q24792227-3F7C6AFD-1F91-4420-A68B-A53C3118CBDDQ26828580-315BC2A1-41F4-4C30-8C84-8BE031F7B535Q30561858-AD33065F-5E7A-4530-9712-C05BAA2309B6Q31021791-55707F2C-F1BF-4E75-AA9D-2862264FFBE4Q33223169-29ACC9A5-8707-46A4-B413-A5E12F6981DBQ33446824-CF17CDE0-1C5C-422E-AF97-F3F55564499CQ33486119-673620E2-566F-4284-BD0A-F7E2B77FB2F3Q33539292-29CEDCD9-FDFE-41AF-B07C-A454EF10D291Q33543108-DABBF5FF-782B-49A3-91C9-1660BEC23605Q33583244-8B538848-396C-43EF-A802-D84D2DC4BED4Q33601225-4AD66905-7B3B-4966-92D5-869E52A9C7D9Q33606758-3653BF5D-4DA3-4002-802B-BDC47A80FDB7Q33625510-1ABD3B7E-C9CE-4AA9-8F6E-D4BA30F1C6AEQ33772150-F60CAE49-DB2A-44C4-B3FC-92E384DD7194Q33795088-F5210750-8696-4154-8828-FAE07D94E404Q33837360-10D6B5B6-007C-49EF-A814-92A715B21E19Q33871483-44CEA8A2-8C5B-431B-872A-2374098A4DD5Q33896976-5FF4184E-3241-43E8-BE00-0474E2EC6916Q33936300-ADBB1DEC-CFE0-4EFD-920E-2DF419042223Q33989350-1DCAF559-666B-4BD1-A8C8-7441B9EBCDCDQ34016237-80F4EBFD-71E0-4007-B6B0-95078E95144AQ34026011-38C3B75A-69DE-424C-A694-822E903965B2Q34067973-70514567-690C-4C2B-B90B-A24566BFA25BQ34104787-ECAFF5F2-81CE-45B0-AB88-B8FED60702C2Q34113148-35473BAC-F555-41CC-AD0E-4D8E9EE65E6FQ34156627-ABFBB970-CD10-4D10-9328-23310C4044BEQ34186908-4DFA1DA0-4D94-4219-B5F7-AC8B028DA76DQ34242772-05CCFDCB-A9BE-46B1-8146-F9200F361528Q34251176-5AE5EF27-4E35-4213-8701-E2552F7E24D9Q34276987-53E3C185-E64A-4DBC-AA52-B39221514C4DQ34277620-44243886-23D9-4D2E-86F9-792C1446970BQ34345801-D702908A-BE52-4E9A-A796-CD2211F72BA3Q34398130-FC15DA21-349E-4EB0-A2DB-E04E954D74F2Q34504887-C7E046C6-627C-4A5B-9A5A-EAE8D903FA77
P2860
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Psychotropic drug use and the risk of hip fracture.
@en
type
label
Psychotropic drug use and the risk of hip fracture.
@en
prefLabel
Psychotropic drug use and the risk of hip fracture.
@en
P2093
P1476
Psychotropic drug use and the risk of hip fracture.
@en
P2093
P304
P356
10.1056/NEJM198702123160702
P407
P577
1987-02-01T00:00:00Z